Report on Systolic Murmur Disorder: Causes, Symptoms, and Treatment

This report provides an overview of systolic murmur disorder, a condition characterized by abnormal heart sounds. It details the diagnostic process, which involves auscultation with a stethoscope and assessment of various characteristics of the murmur. The report also discusses treatment approaches, including medications such as anticoagulants, diuretics, ACE inhibitors, and statins, which target underlying conditions. Furthermore, the report explores the impact of genetics on systolic murmur disorders, highlighting inherited conditions and their symptoms, such as dizziness and palpitations, as well as the diagnostic methods used to identify genetic faults, including family history reviews and genetic testing. The report emphasizes the importance of early detection and treatment to prevent potential complications, including heart failure and sudden death.

Running Head: Systolic Murmur Disorder
Systolic Murmur Disorder

Systolic Murmur Disorder
Systolic Murmur Disorder
Heart Murmurs are the sounds during the heartbeat, which are due to the turbulent blood, the
practitioner can hear them using stethoscope. These sounds can be right after the birth or may
develop during the later stages. These sounds in itself isn’t any disease, however, these
indicate some underlying issues. These are also called as innocent, because they are not
harmful; nevertheless, they require tests to identify any serious heart issue (Reimer, 2018).
Diagnosis
 While the doctor listen the heart sounds using stethoscope
 To test either it normal/innocent or abnormal, the doctor will
o Check if it too loud than normal on a scale of 1-6
o If it is heard from back or the neck, to locate the sound
o How high or low is the pitch
o Is there any change due to posture or exercise
o When does it too loud and for how long it lasts (Leng, san Tan, Chai, Wang, Ghista, &
Zhong, 2015).
Treatment
The underlying condition needs to be treated not the sounds, the sounds fade as the condition
responsible is treated, therefore, it is normal yet could be fatal (Reed, Buitelaar, Anand, Day,
Treuer, Upadhyaya, Savill, 2016).
Medications
1. Anticoagulants: To prevent blood clots, such as aspirin, to avoid heart attack and or stroke.
2. Diuretics: these are water pills to remove excess fluid, this helps to normalize the blood
pressure.
3. Angiotensin: ACE inhibitors: these are responsible to lower the blood pressure
4. Statins: these medicines help reduce the cholesterol, easing the heart valve issues (Kawasaki,
Tanaka, Yoshida, Nagaya, Minatoguchi, Yoshizane, & Noda, 2018).
2

Systolic Murmur Disorder
Impact of genetics on murmur Disorder
The inherited diseases are passed on to the generations, which sometimes may be recessive
and show up as Systolic Murmurs. These can affect as the genes are dominant at any age, or
could be from birth. These can be life threatening and can lead to heart failure, causing
sudden death, if left undetected and or untreated. The first identification or diagnosis is when
the person shows up certain signs without any cause or base explanation (Lee, & Chung,
2016).
What are the symptoms of an inherited heart condition?
However, there may not be any dominant symptom, but the patient may show up symptoms
such as, dizziness, palpitations, and blackouts. According to review, the first sign is
unfortunately when someone loses their life, without any specific cause.
How is an inherited heart condition diagnosed?
The doctor examines the history
1. Any history of diagnosis with angina or a heart attack in family or the patient’s history
2. Any death due to cardiac arrest or premature death due to unidentified cause
The doctors then perform certain medical tests to check the heart condition, along with the
genetic tests to find the faults in the genes which are called cascade testing (Ormondroyd,
Oates, Parker, Blair, & Watkins, 2014).
3

Systolic Murmur Disorder
References
Kawasaki, M., Tanaka, R., Yoshida, A., Nagaya, M., Minatoguchi, S., Yoshizane, T., ... & Noda, T.
(2018). Non-Invasive Pulmonary Capillary Wedge Pressure Assessment on Speckle Tracking
Echocardiography as a Predictor of New-Onset Non-Valvular Atrial Fibrillation―Four-Year
Prospective Study (NIPAF Study)―. Circulation Journal, 82(12), 3029-3036.
Lee, T. M., & Chung, W. K. (2016). Genetics and Hypertrophic Cardiomyopathy. Current Pediatrics
Reports, 4(2), 35-44.
Leng, S., San Tan, R., Chai, K. T. C., Wang, C., Ghista, D., & Zhong, L. (2015). The electronic
stethoscope. Biomedical engineering online, 14(1), 66.
Ormondroyd, E., Oates, S., Parker, M., Blair, E., & Watkins, H. (2014). Pre-symptomatic genetic
testing for inherited cardiac conditions: a qualitative exploration of psychosocial and ethical
implications. European Journal of Human Genetics, 22(1), 88.
Reed, V. A., Buitelaar, J. K., Anand, E., Day, K. A., Treuer, T., Upadhyaya, H. P., ... & Savill, N. C.
(2016). The safety of atomoxetine for the treatment of children and adolescents with
attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of
research. CNS drugs, 30(7), 603-628.
Reimer, J. M. (2018). Cardiovascular disorders. In Equine Pediatric Medicine, Second Edition (pp.
131-150). CRC Press.
4